Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and...

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues Peyrin-Biroulet L, Sandborn WJ, Panaccione R,...

COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation Lev-Tzion R, Focht...

Adherence to mediterranean diet in patients with inflammatory bowel disease Fiorindi C, Dinu M, Gavazzi E, Scaringi S, Ficari F, Nannoni...

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero Flanagan E, Prentice R, Wright EK,...

Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease D'Haens G, Rieder F,...

Natural history of inflammatory bowel disease: a comparison between the East and the West Song EM, Yang SK. Published Dec 2021, in the...

Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With...

Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis Nielsen OH, Gubatan JM,...

Noninvasive Monitoring After Azathioprine Withdrawal in Patients with Inflammatory Bowel Disease in Deep Remission Cassinotti A, Corona...

Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective...

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease...